Literature DB >> 15516709

Update of the drug resistance mutations in HIV-1: 2004.

Victoria A Johnson1, Francoise Brun-Vézinet, Bonaventura Clotet, Brian Conway, Richard T D'Aquila, Lisa M Demeter, Daniel R Kuritzkes, Deenan Pillay, Jonathan M Schapiro, Amalio Telenti, Douglas D Richman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15516709

Source DB:  PubMed          Journal:  Top HIV Med        ISSN： 1542-8826


× No keyword cloud information.
  27 in total

1.  HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance.

Authors:  Soo-Yon Rhee; W Jeffrey Fessel; Andrew R Zolopa; Leo Hurley; Tommy Liu; Jonathan Taylor; Dong Phuong Nguyen; Sally Slome; Daniel Klein; Michael Horberg; Jason Flamm; Stephen Follansbee; Jonathan M Schapiro; Robert W Shafer
Journal:  J Infect Dis       Date:  2005-07-05       Impact factor: 5.226

2.  Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir.

Authors:  José C Clemente; Roxana M Coman; Michele M Thiaville; Linda K Janka; Jennifer A Jeung; Sarawut Nukoolkarn; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Robert McKenna; Wichet Leelamanit; Maureen M Goodenow; Ben M Dunn
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

3.  Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs.

Authors:  Rosario Sabariegos; Mireia Giménez-Barcons; Natalia Tàpia; Bonaventura Clotet; Miguel Angel Martínez
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Oligonucleotide ligation assay for detection of mutations associated with reverse transcriptase and protease inhibitor resistance in non-B subtypes and recombinant forms of human immunodeficiency virus type 1.

Authors:  Yolanda Vega; Lucía Pérez-Alvárez; Elena Delgado; Mercedes Muñoz; Gema Casado; Rocío Carmona; María Sierra; Elena Vázquez de Parga; Milagros Pinilla; Valentina García; Leandro Medrano; Gerardo Contreras; Miguel Thomson; Rafael Nájera
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India.

Authors:  Mohd Azam; Abida Malik; Meher Rizvi; Supriya Singh; Poonam Gupta; Arvind Rai
Journal:  Virus Genes       Date:  2013-07-26       Impact factor: 2.332

6.  High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations.

Authors:  Francesca Ceccherini-Silberstein; Federico Gago; Maria Santoro; Caterina Gori; Valentina Svicher; Fátima Rodríguez-Barrios; Roberta d'Arrigo; Massimo Ciccozzi; Ada Bertoli; Antonella d'Arminio Monforte; Jan Balzarini; Andrea Antinori; Carlo-Federico Perno
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  A population-based and longitudinal study of sexual behavior and multidrug-resistant HIV among patients in clinical care.

Authors:  Michael J Kozal; K Rivet Amico; Jennifer Chiarella; Deborah Cornman; William Fisher; Jeffrey Fisher; Gerald Friedland
Journal:  MedGenMed       Date:  2006-06-13

8.  Evolution of HIV resistance mutations in patients maintained on a stable treatment regimen after virologic failure.

Authors:  Matthew Bidwell Goetz; Monique R Ferguson; Xueliang Han; Greg McMillan; Marty St Clair; Keith A Pappa; Daniel R McClernon; William A O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-15       Impact factor: 3.731

9.  Effectiveness of nonpeptide clinical inhibitor TMC-114 on HIV-1 protease with highly drug resistant mutations D30N, I50V, and L90M.

Authors:  Andrey Yu Kovalevsky; Yunfeng Tie; Fengling Liu; Peter I Boross; Yuan-Fang Wang; Sofiya Leshchenko; Arun K Ghosh; Robert W Harrison; Irene T Weber
Journal:  J Med Chem       Date:  2006-02-23       Impact factor: 7.446

10.  Host sequence motifs shared by HIV predict response to antiretroviral therapy.

Authors:  William Dampier; Perry Evans; Lyle Ungar; Aydin Tozeren
Journal:  BMC Med Genomics       Date:  2009-07-23       Impact factor: 3.063
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.